Literature DB >> 31712772

Joining the dots for better liver cancer treatment.

Lo-Kong Chan1,2, Irene Oi-Lin Ng3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31712772     DOI： 10.1038/s41575-019-0238-3

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  3 in total

1.  Effects of Bacillus subtilis iturin A on HepG2 cells in vitro and vivo.

Authors:  Haobin Zhao; Lu Yan; Ling Guo; Hui Sun; Qingsheng Huang; Dongyan Shao; Chunmei Jiang; Junling Shi
Journal:  AMB Express       Date:  2021-05-10       Impact factor: 3.298

2.  Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.

Authors:  Shu-Kui Qin; Qing Li; Jian Ming Xu; Jun Liang; Ying Cheng; Ying Fan; Jun Jiang; Hao Ye; Huimin Tao; Lian Li; Limin Zheng; Zhaohui Wei; Shu Li; Kun Meng; Bin Ye; Yan Sun
Journal:  Cancer Sci       Date:  2020-09-24       Impact factor: 6.716

3.  DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway.

Authors:  Xiaoyun Hu; Guosheng Yuan; Qi Li; Jing Huang; Xiao Cheng; Jinzhang Chen
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.